Cargando…
Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome thi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Association of Rural Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369407/ https://www.ncbi.nlm.nih.gov/pubmed/32704333 http://dx.doi.org/10.2185/jrm.2019-021 |
_version_ | 1783560775007207424 |
---|---|
author | Fushimi, Saki Horikawa, Yohei Mizutamari, Hiroya Mimori, Nobuya Kato, Yuhei Sato, Sayaka |
author_facet | Fushimi, Saki Horikawa, Yohei Mizutamari, Hiroya Mimori, Nobuya Kato, Yuhei Sato, Sayaka |
author_sort | Fushimi, Saki |
collection | PubMed |
description | Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome this limitation, we compared procedural outcomes and the prevention of adverse events of proton pump inhibitor injection with an orally administered active potassium-competitive acid blocker alone. Participants and Methods: We enrolled a total of 150 patients treated for superficial gastric neoplasms at a single institution between April 2015 and December 2018. Patients treated for 2 days with proton pump inhibitor injections following 12 days of oral potassium-competitive acid blocker (proton pump inhibitor group=80) were compared with patients treated for 14 days orally with potassium-competitive acid blocker alone (potassium-competitive acid blocker group=70) using propensity score analysis. We evaluated intragastric pH levels prior to endoscopic submucosal dissection, frequency of intraoperative major bleeding, procedure time, en bloc resection rate, curability, ulcer reduction rate 14 days after endoscopic submucosal dissection, and adverse events (including perforation and postoperative bleeding). Results: Propensity score analysis yielded 43 matched pairs. The comparison demonstrated similar values for the outcomes. For all cases, we observed intragastric pH levels >6.4 prior to endoscopic submucosal dissection. Postoperative bleeding rates were 2.3% (1/43) in the proton pump inhibitor group and 0.0% (0/43) in the potassium-competitive acid blocker group (P=0.315). Conclusions: Oral potassium-competitive acid blocker alone was as effective as proton pump inhibitor injection, with a low incidence of adverse events. Based on these results, proton pump inhibitor injection might be omitted during gastric endoscopic submucosal dissection. |
format | Online Article Text |
id | pubmed-7369407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japanese Association of Rural Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-73694072020-07-22 Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis Fushimi, Saki Horikawa, Yohei Mizutamari, Hiroya Mimori, Nobuya Kato, Yuhei Sato, Sayaka J Rural Med Original Article Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome this limitation, we compared procedural outcomes and the prevention of adverse events of proton pump inhibitor injection with an orally administered active potassium-competitive acid blocker alone. Participants and Methods: We enrolled a total of 150 patients treated for superficial gastric neoplasms at a single institution between April 2015 and December 2018. Patients treated for 2 days with proton pump inhibitor injections following 12 days of oral potassium-competitive acid blocker (proton pump inhibitor group=80) were compared with patients treated for 14 days orally with potassium-competitive acid blocker alone (potassium-competitive acid blocker group=70) using propensity score analysis. We evaluated intragastric pH levels prior to endoscopic submucosal dissection, frequency of intraoperative major bleeding, procedure time, en bloc resection rate, curability, ulcer reduction rate 14 days after endoscopic submucosal dissection, and adverse events (including perforation and postoperative bleeding). Results: Propensity score analysis yielded 43 matched pairs. The comparison demonstrated similar values for the outcomes. For all cases, we observed intragastric pH levels >6.4 prior to endoscopic submucosal dissection. Postoperative bleeding rates were 2.3% (1/43) in the proton pump inhibitor group and 0.0% (0/43) in the potassium-competitive acid blocker group (P=0.315). Conclusions: Oral potassium-competitive acid blocker alone was as effective as proton pump inhibitor injection, with a low incidence of adverse events. Based on these results, proton pump inhibitor injection might be omitted during gastric endoscopic submucosal dissection. The Japanese Association of Rural Medicine 2020-07-17 2020-07 /pmc/articles/PMC7369407/ /pubmed/32704333 http://dx.doi.org/10.2185/jrm.2019-021 Text en ©2020 The Japanese Association of Rural Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Fushimi, Saki Horikawa, Yohei Mizutamari, Hiroya Mimori, Nobuya Kato, Yuhei Sato, Sayaka Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis |
title | Feasibility of gastric endoscopic submucosal dissection without using proton
pump inhibitor injection: a propensity score analysis |
title_full | Feasibility of gastric endoscopic submucosal dissection without using proton
pump inhibitor injection: a propensity score analysis |
title_fullStr | Feasibility of gastric endoscopic submucosal dissection without using proton
pump inhibitor injection: a propensity score analysis |
title_full_unstemmed | Feasibility of gastric endoscopic submucosal dissection without using proton
pump inhibitor injection: a propensity score analysis |
title_short | Feasibility of gastric endoscopic submucosal dissection without using proton
pump inhibitor injection: a propensity score analysis |
title_sort | feasibility of gastric endoscopic submucosal dissection without using proton
pump inhibitor injection: a propensity score analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369407/ https://www.ncbi.nlm.nih.gov/pubmed/32704333 http://dx.doi.org/10.2185/jrm.2019-021 |
work_keys_str_mv | AT fushimisaki feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis AT horikawayohei feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis AT mizutamarihiroya feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis AT mimorinobuya feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis AT katoyuhei feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis AT satosayaka feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis |